University of Crete (UOC)
Η χρήση ποδοκυτταρικών δεικτών στην πρώιμη διάγνωση της διαβητικής νεφροπάθειας
Abstract
dc:descriptionBackground: Diabetes mellitus (DM) is a chronic illness characterized by impairedmetabolism of carbohydrates, fat and protein secondary to a deficiency in secretionand/or action of insulin. Diabetic kidney disease (DKD) is a major complication of DM and many of these patients develop end-stage renal disease. Albuminuria has traditionallybeen used for the diagnosis and classification of DKD. Podocyte injury plays a crucial role in the pathogenesis and progression of DKD. Therefore, we investigated whether patients with DM and normoalbuminuria present podocyte markers in urine suggestive of early podocyte injury.Methods: We studied 80 patients with type 2 DM who were examined at the DiabetesClinic of the University Hospital of Heraklion, Crete, from January to June 2011.Exclusion criteria were (1) history of renal disease, (2) history of micro ormacroalbuminuria, (3) presence of urinary infection, (4) known duration of DM <1year and (5) use of nephrotoxic medication. We also studied 50 non-diabeticcontrols. All the subjects were categorized according to their urinary podocyte marker profile into 2 groups, those with only synaptopodin mRNA presence (synaptopodin only group) and those with nephrin and/or podocin mRNA presence in addition to synaptopodin in their urine (nephrin and/or podocin group).Results: Nine diabetic patients and 11 controls had increased urinary albumin excretion (UAE) on enrolment and, therefore, were not included in analysis. Among 71 normoalbuminuric patients with type 2 DM and 39 non-diabetic controls, synaptopodin mRNA was detected in the urine of all the diabetics and controls. The presence of nephrin and/or podocin mRNA in urine was more frequent among DM patients compared to controls (53.5 vs. 30.8%, respectively; p = 0.022). Binary logistic regression analysis revealed that the only significant predictor of the presence of nephrin and/or podocin mRNA in urine was the presence of DM (OR 2.59, 95% CI 1.14–5.91, p = 0.024, adjusted for all risk factors). A strong correlation between nephrin and podocin urinary mRNA levels was noted (r = +0.796, p < 0.001).Conclusion: Overall, this study demonstrated the presence of podocyte markers in the urine of normoalbuminuric diabetic patients. Nephrin and podocin mRNA is more prevalent in diabetic patients with normal UAE compared to controls, and this may reflect early podocyte injury. DM was the only significant determinant of their presence in urine of this population. Synaptopodin mRNA was uniformly detected in all the subjects independent of their DM status and, thus, synaptopodin is unsuitable for the diagnosis of podocyte injury. Therefore, it appears of particular importance to prospectively evaluate normoalbuminuric diabetic patients with urinary nephrin and/or podocin mRNA and identify a potential increased risk of DKD and if early treatment, for example, with angiotensin-converting enzyme inhibitors may retard the development of renal injury.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lioudaki, Eirini
- Λιουδάκη, Ειρήνη
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37004